Endexx Acquires Cann-Can LLC.
Endexx's Medical Marijuana Movement into Dispensing and Vending Technologies
PHOENIX, April 9, 2013 /PRNewswire/ -- Endexx Corporation (OTC Markets: EDXC) announces the acquisition of Cann-Can LLC. Endexx has acquired all rights and property of Cann-Can from LEDXChange LLC., including its prototype accessory vending machine, the website www.cann-can.com, all Research and Development and social media.
In addition to the acquisition, Endexx has engaged David Levine, Cann-Can's founder and developer, as a specialty consultant. As a pioneer in the MMJ vending machine services arena, Mr. Levine brings years of unique experience in our focused industry.
Mr. Levine specializes in technology solutions, including hardware and software design in the vending machine services sector. Todd Davis, CEO Endexx stated, "David's insight, experience and knowledge, uniquely complements our objective to create revenue models that are in line with our compliance platform and scientific approach to the management side of the Medical Marijuana Industry."
David Levine, founder of Cann-Can states, "As one of the first producers of Medical Marijuana accessory machines, and as a vending industry consultation firm that specializes in alternative forms of vending, Cann-Can LLC is proud to become part of the Endexx Corporation. We believe that this partnership will produce many exciting products in the near future and feel that Endexx Corporation is an ideal suitor for our company."
Endexx continues to search for additional technology acquisitions and seeks to establish key market and alliance partners in the Medical Marijuana Industry. Multiple developments are underway, as well, the new website for Endexx is nearing launch date.
Additionally, our subsidiary websites are in various stages of development. Website design today must accommodate desktop, tablet, smart phone and multiple code language protocols, adding increased timelines for design and full functionality.
Endexx encourages clear lines of communication to the public and welcomes contact via email. Endexx will provide all shareholders via email and public news wire services, all material information that is newsworthy and identifies value to its shareholders. Endexx looks forward to building a sustainable industry platform creating long term success for its shareholders and business partners.
Contact: Todd Davis CEO
Contact Endexx via email to receive corporate news and updates.
Safe Harbor Statement
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word "believe" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Endexx to differ materially from those implied or expressed by such forward-looking statements. This press release speaks as of the date first set forth above, and Endexx assumes no responsibility to update the information included herein for events occurring after the date hereof. Actual results could differ materially from those anticipated due to factors such as the lack of capital, timely development of products, inability to deliver products when ordered, inability of potential customer to pay for ordered products, and political and economic risks inherent in international trade.
SOURCE Endexx Corporation
More by this Source
Endexx enters definitive agreement to acquire THCFinder.com
Sep 28, 2013, 14:32 ET
Endexx Secures Exclusive World Wide Rights for Medical Marijuana Dispensing Technology
Aug 12, 2013, 09:00 ET
Endexx closes Acquisition of Dispense Labs LLC.
Aug 07, 2013, 09:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.